ACERUS OTC Stock Performance

The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. Let's try to break down what ACERUS's beta means in this case. the returns on MARKET and ACERUS PHARMACEUTICALS are completely uncorrelated. Although it is extremely important to respect ACERUS PHARMACEUTICALS historical returns, it is better to be realistic regarding the information on equity current trending patterns. The approach to foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By evaluating ACERUS PHARMACEUTICALS technical indicators, you can at this time evaluate if the expected return of 0.0% will be sustainable into the future. ACERUS PHARMACEUTICALS at this moment shows a risk of 0.0%. Please confirm ACERUS PHARMACEUTICALS downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to decide if ACERUS PHARMACEUTICALS will be following its price patterns.

ACERUS O TC Stock Performance 

ACERUS Performance
0 of 100
Over the last 90 days ACERUS PHARMACEUTICALS CORP has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, ACERUS PHARMACEUTICALS is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Quick Ratio0.35
Fifty Two Week Low0.0200
Fifty Two Week High0.0700

ACERUS PHARMACEUTICALS Relative Risk vs. Return Landscape

If you would invest (100.00)  in ACERUS PHARMACEUTICALS CORP on September 7, 2021 and sell it today you would earn a total of  100.00  from holding ACERUS PHARMACEUTICALS CORP or generate -100.0% return on investment over 90 days. ACERUS PHARMACEUTICALS CORP is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than ACERUS, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
 Daily Expected Return (%) 
      Risk (%) 


Today, many novice investors tend to focus exclusively on investment returns with little concern for ACERUS PHARMACEUTICALS's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as ACERUS PHARMACEUTICALS CORP, and traders can use it to determine the average amount a ACERUS PHARMACEUTICALS's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Good Returns
Average Returns
Small Returns
Based on monthly moving average ACERUS PHARMACEUTICALS is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ACERUS PHARMACEUTICALS by adding it to a well-diversified portfolio.


Checking the ongoing alerts about ACERUS PHARMACEUTICALS for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ACERUS PHARMACEUTICALS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.


Equity Alerts and Improvement Suggestions

ACERUS PHARMACEUTICALS is not yet fully synchronised with the market data
ACERUS PHARMACEUTICALS has some characteristics of a very speculative penny stock
ACERUS PHARMACEUTICALS has high likelihood to experience some financial distress in the next 2 years
The company has accumulated 13.16 M in total debt with debt to equity ratio (D/E) of 2.61, implying the company greatly relies on financing operations through barrowing. ACERUS PHARMACEUTICALS has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
The entity reported the revenue of 1.56 M. Net Loss for the year was (34.05 M) with loss before overhead, payroll, taxes, and interest of (929 K).
ACERUS PHARMACEUTICALS CORP has accumulated about 2.6 M in cash with (23.57 M) of positive cash flow from operations.
Roughly 91.0% of ACERUS PHARMACEUTICALS shares are held by company insiders
Check out Trending Equities. Note that the ACERUS PHARMACEUTICALS information on this page should be used as a complementary analysis to other ACERUS PHARMACEUTICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Tools for ACERUS OTC Stock

When running ACERUS PHARMACEUTICALS price analysis, check to measure ACERUS PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACERUS PHARMACEUTICALS is operating at the current time. Most of ACERUS PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of ACERUS PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ACERUS PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of ACERUS PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity